These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1073 related items for PubMed ID: 17540803
1. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, Connor JM, Dobbie R. Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803 [Abstract] [Full Text] [Related]
6. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE. Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463 [Abstract] [Full Text] [Related]
7. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study. Bergen NE, Bouwland-Both MI, Steegers-Theunissen RP, Hofman A, Russcher H, Lindemans J, Jaddoe VW, Steegers EA. Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264 [Abstract] [Full Text] [Related]
11. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Boutin A, Guerby P, Gasse C, Tapp S, Bujold E. Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265 [Abstract] [Full Text] [Related]
12. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia]. Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X. Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913 [Abstract] [Full Text] [Related]
13. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience. Müller A, Horvat V, Vulin M, Mandić S, Šerić V, Vidosavljević D. Med Glas (Zenica); 2019 Feb 01; 16(1):53-59. PubMed ID: 30680983 [Abstract] [Full Text] [Related]
14. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study. MacDonald TM, Tran C, Kaitu'u-Lino TJ, Brennecke SP, Hiscock RJ, Hui L, Dane KM, Middleton AL, Cannon P, Walker SP, Tong S. BMC Pregnancy Childbirth; 2018 Aug 31; 18(1):354. PubMed ID: 30170567 [Abstract] [Full Text] [Related]
15. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Coolman M, Timmermans S, de Groot CJ, Russcher H, Lindemans J, Hofman A, Geurts-Moespot AJ, Sweep FC, Jaddoe VV, Steegers EA. Obstet Gynecol; 2012 Jun 31; 119(6):1190-200. PubMed ID: 22617584 [Abstract] [Full Text] [Related]
16. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia. Stolz M, Zeisler H, Heinzl F, Binder J, Farr A. Pregnancy Hypertens; 2018 Jan 31; 11():54-60. PubMed ID: 29523274 [Abstract] [Full Text] [Related]